谷歌诺华携手研发智能隐形眼镜技术，可矫正老花眼

    我认为，这一合作关系从眼部开始至关重要，因为眼睛确实是人体整体健康状况的窗口。不过，除了眼科，诺华在众多临床治疗领域都是全球领导者。

    其中之一就是肿瘤学，或者说癌症治疗，今后这一领域可能也会有其他机会。在心力衰竭领域也会有各种机会。我们已获得了一条极佳渠道有望治疗患有慢性心力衰竭的病人，还具备了开拓目前就医需求强烈的领域的多种条件。

    将这一技术与爱尔康自己的产品开发整合起来的最大挑战是什么？

    要知道，从技术挑战这一角度看，事情并不容易。我们刚才谈到了嵌入传感器、微型无线芯片和微芯片。而如何才能确保在血糖监测智能隐形眼镜上使葡萄糖和血糖之间具有相关性呢，还有其他需要在临床上加以验证的很多东西。

    所以，我认为既有谷歌擅长解决的技术难题，也有诺华和爱尔康擅长应对的临床难题。

    你认为科技公司和制药公司今后会开展更多此类合作吗？

    我确实发现科技和医疗保健业有日益融合的趋势。而我认为，科技公司不仅要找到新的增长点，也需要找到能真正影响世界的全新方式。

    正如谢尔盖•布林昨天所说，这种合作有望帮助全世界成千上万的患者。对诺华和爱尔康来说，这种合作确实充满了使命感，我尽管不想为谷歌代言，但我想对他们来说事实也是如此。

    I think it’s important that the partnership is starting with the eye, which is really the natural window into the body’s overall health. But, moving beyond the eye, Novartis is clearly a leader globally in a number of therapeutic areas.

    One of those that we’re a leader in is oncology, or the treatment for cancer, and there could be other opportunities in the future in that space. There could be other opportunities in heart failure. We’ve got a pretty incredible pipeline that’s looking to address people with chronic heart failure and a number of conditions right now where there’s a pretty high medical need.

    What will be the biggest challenge incorporating the technology into Alcon’s own product development?

    From the technical challenge perspective, you know, this isn’t easy. You’re talking about layering in sensors and miniature wireless chips and microchips. Then, how do you ensure on the gluco-sensing smart lens that there’s a correlation between the sugar glucose and the blood glucose, plus a number of other things that we need to prove clinically.

    So, I think there are both technical challenges, which is really where Google excels, and there’s also clinical challenges, which is really where Novartis and Alcon excel.

    Do you see more partnerships like this happening in the future between technology and pharmaceutical companies?

    I do see an increasing convergence in technology and healthcare, and I think technology companies are looking for new sources of growth but also new ways in which they can really impact the world.

    As Sergey [Brin] said in his quote yesterday, this has the potential to help millions of people around the world. There’s a real mission component to this for us on the Novartis and the Alcon side, and I think that’s true for Google as well, though I wouldn’t want to speak for them.